A/DT
new/JJ
member/NN
of/IN
the/DT
leucine/NN
zipper/NN
class/NN
of/IN
proteins/NNS
that/WDT
binds/VBZ
to/TO
the/DT
HLA/NN
DR/NN
alpha/NN
promoter/NN
./.

Several/JJ
mutants/NNS
derived/VBN
from/IN
transformed/VBN
human/JJ
B/NN
cell/NN
lines/NNS
are/VBP
defective/JJ
in/IN
expressing/VBG
major/JJ
histocompatibility/NN
complex/NN
(/(
MHC/NN
)/)
class/NN
II/CD
genes/NNS
./.
=====
The/DT
failure/NN
to/TO
express/VB
a/DT
class/NN
II/CD
gene/NN
in/IN
at/IN
least/JJS
one/CD
such/JJ
mutant/JJ
line/NN
has/VBZ
been/VBN
mapped/VBN
to/TO
the/DT
MHC/NN
class/NN
II/CD
X/NN
box/NN
,/,
a/DT
conserved/VBN
transcriptional/JJ
element/NN
in/IN
the/DT
promoter/NN
region/NN
./.
=====
A/DT
complementary/JJ
DNA/NN
encoding/VBG
a/DT
DNA-binding/JJ
protein/NN
(/(
human/JJ
X/NN
box/NN
binding/NN
protein/NN
,/,
hXBP-1/NN
)/)
whose/WP$
target/NN
is/VBZ
the/DT
human/JJ
DR/NN
alpha/NN
X/NN
box/NN
and/CC
the/DT
3'/JJ
flanking/JJ
region/NN
has/VBZ
now/RB
been/VBN
cloned/VBN
./.
=====
This/DT
complementary/JJ
DNA/NN
encoded/VBD
a/DT
protein/NN
with/IN
structural/JJ
similarities/NNS
to/TO
the/DT
c-jun/NN
proto-oncogene/NN
product/NN
,/,
and/CC
its/PRP$
target/NN
sequence/NN
was/VBD
closely/RB
related/JJ
to/TO
the/DT
palindromic/JJ
target/NN
sequence/NN
of/IN
c-jun/NN
./.
=====
Mutation/NN
of/IN
the/DT
hXBP-1/NN
DNA/NN
target/NN
sequence/NN
decreased/VBD
DR/NN
alpha/NN
promoter/NN
activity/NN
in/FW
vivo/FW
./.
=====
These/DT
studies/NNS
suggest/VBP
that/IN
the/DT
hXBP-1/NN
protein/NN
acts/VBZ
as/IN
a/DT
transcription/NN
factor/NN
in/IN
B/NN
cells/NNS
./.